|
시장보고서
상품코드
2058289
정신질환 치료 시장 : 질환 종류별, 약물별, 유통 채널별, 지역별Mental Disorder Treatment Market, By Disorder Type, By Medication, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
정신질환 치료 시장은 2026년에 751억 달러로 추정되며, 2033년까지 1,167억 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 6.6%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 751억 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 6.60% | 2033년 시장 규모 예측: | 1,167억 달러 |
정신질환에는 우울증, 양극성 장애, 조현병, 치매, 외상 후 스트레스 장애(PTSD) 등 다양한 종류가 포함됩니다. 이러한 정신 질환은 약물 치료나 심리 치료를 통해 치료됩니다. 또한, 이러한 정신 질환의 치료에 사용되는 약물로는 항우울제, 항불안제, 항정신병제, 기분 안정제 등이 있습니다.
시장 역학
주요 기업들은 세계 정신질환 치료 시장에서의 입지를 강화하기 위해 우울증 및 양극성 장애 등 정신질환 치료제 출시를 위해 주력하고 있습니다. 예를 들어, 2017년에는 루핀 리미티드가 주요 우울 장애 치료용 항우울제인 '부프로피온 염산염 서방정'을 미국 시장에 출시했습니다.
본 조사의 주요 특징
- 본 보고서는 전 세계 정신질환 치료 시장의 현황 및 향후 전망에 대해 조사하고 있습니다. 이 시장은 질환 유형, 의약품, 유통 채널 및 지역을 기준으로 세분화되어 있습니다.
- 본 보고서는 전 세계 정신질환 치료 시장에 대한 상세한 분석을 바탕으로, 예측 기간(2026-2033년) 동안의 시장 규모 및 연평균 성장률(CAGR, %)을 제시하고 있습니다.
- 본 보고서는 각 부문별 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다. 또한, 시장 촉진요인, 시장 억제요인, 기회, 국가별 전망 및 주요 기업들이 채택하고 있는 경쟁 전략에 대한 귀중한 인사이트를 제공합니다.
- 본 보고서에서는 다음의 주요 지표를 바탕으로 전 세계 정신질환 치료 시장의 주요 기업들을 분석하고 있습니다 : 기업 개요, 재무 실적, 제품 포트폴리오, 사업 전개 지역, 주요 발전 사항 및 향후 계획.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 정신질환 치료 시장 보고서는 투자자, 제품 개발자 및 제조업체, 유통업체, 의료 기관, 연구 기관, 신규 진입 기업, 금융 애널리스트 등 해당 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 정신질환 치료 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정 과정에서 큰 이점을 얻을 수 있습니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 정신질환 치료 시장 : 질환 유형별, 2021-2033년
제5장 세계의 정신질환 치료 시장 : 치료제별, 2021-2033년
제6장 세계의 정신질환 치료 시장 : 유통 채널별, 2021-2033년
제7장 세계의 정신질환 치료 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고문헌 및 조사 방법
KSM 26.06.19Mental Disorder Treatment Market is estimated to be valued at USD 75.1 Bn in 2026 and is expected to reach USD 116.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 75.1 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.60% | 2033 Value Projection: | USD 116.7 Bn |
The mental disorder include various different types of mental disorders such as depression, bipolar disorder, schizophrenia, dementia, post traumatic disorders, and others. These mental disorders are treated with the help of medications or psycho-therapies. Moreover, various medications used for the treatment of these mental disorders include anti-depressants, anti-anxiety medications, anti-psychotic medications, and mood stabilizing medication.
Market Dynamics
Key companies are focusing on product launches for the treatment of mental disorders such as depression, bipolar disorders to strengthen their position in the global mental disorder treatment market. For instance, in 2017, Lupin Limited, launched its anti-depressant, Bupropion Hydrochloride extended release tablets, indicated for the treatment of major depressive disorder, in the U.S. market.
Key features of the study
- This report studies the current scenario as well as the future potential of the global mental disorder treatment market. The market for is segmented on basis of disorder type, medication, distribution channel, and region.
- This report provides in-depth analysis of the global mental disorder treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR) (%) for the forecast period (2026-2033)
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by leading players.
- It profiles leading players in the global mental disorder treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
- Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
- The global mental disorder treatment market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
- Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global mental disorder treatment market
Market Segmentation
- By Disorder Type (Revenue, USD Bn, 2021-2033)
- Depression
- Bipolar Disorder
- Schizophrenia
- Dementia
- Post-traumatic stress disorder
- Others
- By Medication (Revenue, USD Bn, 2021-2033)
- Anti-depressants
- Anti-anxiety
- Mood Stabilizing Medication
- Antipsychotic Medications
- By Distribution Channel (Revenue, USD Bn, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Mental Disorder Treatment Market, By Region: (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Allergan plc
- Eli Lilly and Company
- VistaGen Therapeutics
- Sanofi S.A
- Novartis International AG
- Mylan N.V.
- Amneal Pharmaceuticals LLC
- Cipla Ltd
- Sun Pharmaceutical Industries Ltd.
- Glenmark Pharmaceuticals Limited
- Lupin Limited
- Janssen Pharmaceutica
- Bristol Myers Squibb
- Sumitomo Dainippon Pharma Co., Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Disorder Type
- Market Snapshot, By Medication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Key Developments
- New Product Launches/Approvals
- Merger-Acquisition Scenario
- Regulatory Scenario
- Pipeline Analysis
- Epidemiology
- PEST Analysis
- Reimbursement
4. Global Mental Disorder Treatment Market, By Disorder Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Depression
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Bipolar Disorder
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Schizophrenia
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Dementia
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Post-traumatic Stress Disorder
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Others
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
5. Global Mental Disorder Treatment Market, By Medication, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Anti-depressants
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Anti-anxiety
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Mood Stabilizing Medication
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Antipsychotic Medications
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
6. Global Mental Disorder Treatment Market, By Distribution Channel, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
7. Global Mental Disorder Treatment Market, By Region, 2021-2033 (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 - 2033
- North America
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Disorder Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Medication, 2021-2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
- U.S.
- Canada
- Latin America
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Disorder Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Medication, 2021-2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Disorder Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Medication, 2021-2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Disorder Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Medication, 2021-2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Disorder Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Medication, 2021-2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Disorder Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By Medication, 2021-2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
- South Africa
- Central Africa
- North Africa
8. Competitive Landscape
- Company Profiles
- Allergan plc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Eli Lilly and Company
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- VistaGen Therapeutics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sanofi S.A
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis International AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Mylan N.V.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Amneal Pharmaceuticals LLC
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cipla Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Glenmark Pharmaceuticals Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Lupin Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Janssen Pharmaceutica
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bristol Myers Squibb
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sumitomo Dainippon Pharma Co., Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Allergan plc
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
